Chemotherapeutic agents may adversely affect the nervous system, including the neural
precursor cells as well as the white matter. Although the mechanisms are not completely …

The advent of new technologies has paved the rise of various chemicals that are being
employed in industrial as well as consumer products. This leads to the accumulation of …

Even with recent progress, cancer remains the second leading cause of death, outlining a
need to widen the current understanding on oncogenic factors. Accumulating evidence from …

Multiple myeloma (MM) is a malignant cancer with an increasing in incidence that can be
alleviated through bortezomib (BTZ) treatment. Activating transcription factor 3 (ATF3) plays …

Myelodysplastic Syndromes (MDSs) affect the elderly and can progress to Acute Myeloid
Leukemia (AML). Epigenetic alterations including DNA methylation and chromatin …

Objectives: Premature birth, defined as less than 37 weeks gestation, affects approximately
12% of all live births around the world. Advances in neonatal care have resulted in the …

Ricin toxin (RT) is one of the most lethal type II ribosome-inactivating proteins (RIP), and is
classified as a potential bioterror agent due to its severe cytotoxicity and high availability …

Despite that androgen-deprivation therapy results in long-lasting responses, the disease
inevitably progresses to metastatic castration-resistant prostate cancer. In this study, we …

Peripheral neuropathy is one of the main side-effects of novel therapeutics used in
oncohematological diseases, but the molecular basis underlying its development and …

Multiple myeloma (MM) is a plasma cell malignancy that, despite recent advances in
therapy, continues to pose a major challenge to hematologists. Currently, different classes of …